Follow-up Study After Manchester Operation for Pelvic Organ Prolapse
NCT ID: NCT02246387
Last Updated: 2023-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
209 participants
OBSERVATIONAL
2014-10-31
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to:
* prospectively evaluate if cardinal/sacrouterine ligament plication (as part of the 3-compartment Manchester procedure) gives an adequate elevation and fixation of the vaginal apex.
* assess changes in subjective symptoms between the preoperative evaluation and the 1 and 5-year postoperative evaluations.
* evaluate whether the patients identified with levator avulsions in the investigators population have an increased risk of failure (objectively and subjectively).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Laparoscopic Pectopexy and Laparoscopic Lateral Suspension Surgeries
NCT05930795
A Randomized Controlled Trail of Uterosacral Ligament Suspension in the Treatment of Pelvic Organ Prolapse
NCT06418438
Evaluation of Sexual Function and Quality of Life Tests in Patients Who Underwent Manchester Operation for Pelvic Organ Prolapse
NCT06975956
Effectiveness of Perineorrhaphy in Pelvic Organ Prolapse Surgery
NCT07006129
Lateral Suspension Versus Sacral Colpopexy POP
NCT03644628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main justification for this study is that the investigators already have identified a surgical technique that has documented excellent results, but studies with more detailed data quality are needed in order to better evaluate the procedure's advantages and potential disadvantages. As the use of mesh in vaginal surgery has shown unacceptable high risks of new and serious complications, there is an international focus and interest in traditional native tissue repairs and how to optimize their performance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Manchester Operation
Manchester Operation: Native tissue repair
Manchester Operation
A 3- compartment native tissue repair procedure for Pelvic Organ Prolapse.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Manchester Operation
A 3- compartment native tissue repair procedure for Pelvic Organ Prolapse.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjective distress from pelvic organ prolapse
* Cystocele Stage I - III with descent of the cervix Stage I-III, with or without a defect of the posterior wall (rectocele, enterocele, hypotrophic perineum).
Exclusion Criteria
* Previous surgery for POP
* Patients with a true Uterine prolapse with a descent of the corpus uteri stage II-III and not just an elongated cervix, as this group may benefit from other procedures than a Manchester operation (vaginal hysterectomy and sacrospinous fixation)
* Unable to understand patient information (in Norwegian or English) and sign an informed consent.
* Patients in whom a colpocleisis (closing of the vagina) is deemed the better surgical treatment, such as in elderly women not sexually active and not interested in future vaginal intercourse.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sissel Oversand
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sissel H Oversand, MD
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Anne C Staff, PhD
Role: STUDY_CHAIR
Oslo University Hospital; University of Oslo
Rune Svenningsen, PhD
Role: STUDY_DIRECTOR
Oslo University Hospital; University of Oslo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gynekologisk avdeling, Oslo Universitetssykehus Ullevål
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/2093/REK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.